Ayala King
- Ophthalmology top 5%
- Retinal Diseases and Treatments 2
-
- Retinal Development and Disorders 3
- Epigenetics and DNA Methylation 2
- Bone Metabolism and Diseases 2
- Metabolomics and Mass Spectrometry Studies 1
-
- Cancer, Hypoxia, and Metabolism 2
-
- Advanced Glycation End Products research 2
-
- Amino Acid Enzymes and Metabolism 1
- Co-authors
- Eyal GottliebJoshua L. DunaiefMichael P. MurphyDavid G. BrooksDavid J. GoldhamerCharles P. EmersonMoshe ShaniBrian P. Brunk
- Journals
- Scientific Reports (2 papers)Photochemistry and Photobiology (2 papers)Current Opinion in Cell Biology (1 paper)
- Partner nations
- United KingdomUnited StatesIsrael
In The Last Decade
Ayala King
13 papers receiving 816 citations
Peers
Comparison fields: 5 of 96
- Ophthalmology 144
- Molecular Biology 633
- Cancer Research 129
- Aging 9
- Cell Biology 68
Countries citing papers authored by Ayala King
This map shows the geographic impact of Ayala King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayala King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayala King more than expected).
Fields of papers citing papers by Ayala King
This network shows the impact of papers produced by Ayala King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayala King. The network helps show where Ayala King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ayala King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 6 | |
| 2 | 2017 | 11 | |
| 3 | 2015 | 28 | |
| 4 | 2015 | 4 | |
| 5 | 2015 | 205 | |
| 6 | 2015 | 32 | |
| 7 | HIRA orchestrates a non-canonical dynamic chromatin landscape in senescence and is required for suppression of neoplasia | 2014 | 0 |
| 8 | 2013 | 47 | |
| 9 | 2011 | 69 | |
| 10 | 2009 | 43 | |
| 11 | 2004 | 192 | |
| 12 | 2004 | 24 | |
| 13 | 2002 | 10 | |
| 14 | 1995 | 157 |
About Ayala King
Ayala King is a scholar working on Ophthalmology, Clinical Biochemistry and Cancer Research, having authored 14 papers that have together received 828 indexed citations. Recurring topics across this work include Retinal Development and Disorders (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epigenetics and DNA Methylation (2 papers), Retinal Diseases and Treatments (2 papers), Advanced Glycation End Products research (2 papers), Bone Metabolism and Diseases (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Ophthalmology (144 citations), Molecular Biology (633 citations) and Cancer Research (129 citations). Ayala King has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include Eyal Gottlieb, Joshua L. Dunaief, Michael P. Murphy, David G. Brooks, David J. Goldhamer, Charles P. Emerson, Moshe Shani, Brian P. Brunk, Alexander Faerman and Karen Blyth. Their work appears in journals such as Scientific Reports, Photochemistry and Photobiology, Current Opinion in Cell Biology, Seminars in Cell and Developmental Biology and Current Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.